BIOTRON LIMITED - Announcements

25.0%

0.3¢

Market Cap $3.318M

Healthcare Biotechnology

Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the... Biotron Limited is a clinical-stage biotechnology company. The Company is engaged in the research, development, and commercialization of drugs targeting significant viral diseases with unmet medical need. The Company has BIT225 in clinical development for HIV-1 and COVID-19, and additional preclinical programs including Hepatitis B Virus (HBV). In addition, the Company has several early-stage programs designing drugs that target a class of virus protein known as viroporins, which have a key role in the virus life cycle of a range of viruses, such as Coronavirus, Dengue, Ebola, Middle East Respiratory virus, Influenza and Zika viruses. Its proprietary primary bacterial cell-based screening platform enables rapid screening of target viroporin proteins. Its lead compound, BIT225, is in Phase II development for the treatment of HIV-1. The Company also has a portfolio of preclinical antiviral programs.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

BIT	New Issue - Appendix 3B	PRICE SENSITIVE	04/04/11	116.25KB	Share
BIT	Presentation to Investors		31/03/11	1.42MB	Share
BIT	Trading Halt	PRICE SENSITIVE	31/03/11	52.38KB	Share
BIT	Biotron Share Purchase Plan		28/03/11	148.45KB	Share
BIT	Letter to Shareholders		16/03/11	309.15KB	Share
BIT	Stage 1 of Landmark HCV Drug Trial Completed	PRICE SENSITIVE	10/03/11	52.67KB	Share
AAX +ABQ ADY CT1 AIV AKF APE DXC ARA AUK AZT AZX BBG BBL BIT BPO HPP BUL CCD CDD CLH CNH COI COK CPB CTO AQX DML DON DTG DVN EBG EMM ERA EXE FKP FLT GBP JNS GLL GPM AMN GWA HBS HIG QXR ICN IDL JIN KME LAU LDW MCC MNZ MST NHC OAK OCE OVT PAX PGL SKY PNA PNN PNR QRN RCT RFG RFX RPF RPX RUL SAP SDM SMR SUM SWL SXR TPA TPI TXN CR3 VBA VTG WBB WEC WHC WIG WTF WTP	Change of Share Registry Address		07/03/11	65.93KB	Share
BIT	Appendix 3B		02/03/11	72.08KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	28/02/11	185.6KB	Share
BIT	Biotron Share Purchase Plan	PRICE SENSITIVE	24/02/11	105.07KB	Share
BIT	Response to ASX Query re Appendix 4C	PRICE SENSITIVE	07/02/11	43.53KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/11	49.08KB	Share
BIT	US BIOTECH SHOWCASE PRESENTATION		12/01/11	1.82MB	Share
BIT	Grant of Options and Appendices 3B and 3Y		24/12/10	67.65KB	Share
BIT	Security Trading Policy		23/12/10	65.06KB	Share
BIT	Appendix 3B		02/12/10	68.17KB	Share
BIT	Results of Meeting		26/11/10	23.3KB	Share
BIT	Presentation to Annual General Meeting		26/11/10	769.01KB	Share
BIT	International Study Supports Biotron's HIV Drug Approach	PRICE SENSITIVE	25/11/10	50.56KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/10	49.21KB	Share
BIT	Annual Report and Notice of Annual General Meeting		27/10/10	4.44MB	Share
BIT	Presentation to Investors		20/10/10	178.38KB	Share
BIT	Letter to Shareholders		14/10/10	221.89KB	Share
BIT	Phase II HCV Trial Commenced	PRICE SENSITIVE	01/10/10	67.7KB	Share
BIT	Preliminary Final Report	PRICE SENSITIVE	31/08/10	966.84KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	30/07/10	49.29KB	Share
BIT	Presentation at International AIDS Conference	PRICE SENSITIVE	23/07/10	35.02KB	Share
BIT	Letter to Shareholders		30/06/10	269.58KB	Share
BIT	Appendix 3B		28/05/10	68.27KB	Share
BIT	Change of Director's Interest Notice		19/05/10	28.09KB	Share
BIT	Appointment of a Director		30/04/10	26.41KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	22/04/10	49.25KB	Share
BIT	Exercise of Options and Appendix 3B		08/04/10	62.11KB	Share
BIT	Director Resignation		01/04/10	27.16KB	Share
BIT	Shareholder Update and 'Piggy Back' Options Opportunity		19/03/10	359.73KB	Share
BIT	Biotron HCV Drug - International Partner to Progress Trial	PRICE SENSITIVE	18/03/10	68.17KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/10	95.53KB	Share
BIT	Allotment and Top 20 securityholders - Options		05/02/10	38.09KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/10	49.19KB	Share
BIT	Change of Director's Interest Notices		22/01/10	34.56KB	Share
BIT	Entitlement Issue 23% Oversubscribed		15/01/10	21.07KB	Share
BIT	Breakthrough HIV Treatment Progresses	PRICE SENSITIVE	17/12/09	24.82KB	Share
BIT	HCV Drug Success Presented to International Conference	PRICE SENSITIVE	14/12/09	70.8KB	Share
BIT	Option Entitlement Issue and Appendix 3B	PRICE SENSITIVE	10/12/09	473.84KB	Share
BIT	Trading Halt	PRICE SENSITIVE	09/12/09	59.44KB	Share
BIT	Response to ASX Query re Appendix 4C	PRICE SENSITIVE	17/11/09	67.24KB	Share
BIT	BIOTRON'S ANTI-HCV DRUG RECOGNISED INTERNATIONALLY		10/11/09	579.96KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	27/10/09	49.01KB	Share
BIT	Results of Meeting		16/10/09	23.16KB	Share
BIT	Presentation to Annual General Meeting		16/10/09	167.3KB	Share
BIT	Shareholder Update on the Successful Hepatitis C Human Trial		14/10/09	249.63KB	Share
BIT	Successful HCV Trial Results	PRICE SENSITIVE	06/10/09	34.43KB	Share
BIT	Annual Report and Notice of AGM		29/09/09	1.14MB	Share
BIT	Preliminary Final Report	PRICE SENSITIVE	28/08/09	305.11KB	Share
BIT	Completion of Clinical Stage of HCV Trial	PRICE SENSITIVE	04/08/09	79.29KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	24/07/09	49.11KB	Share
BIT	Response to ASX Query - Director's Interest Notice		04/05/09	67.17KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/09	56.03KB	Share
BIT	New Issue Annoucement and HCV Trial Update	PRICE SENSITIVE	14/04/09	75.24KB	Share
BIT	Trading Halt	PRICE SENSITIVE	09/04/09	57.35KB	Share
BIT	Change of Director's Interest Notice		06/04/09	34.58KB	Share
BIT	Letter to Shareholders		05/03/09	126.56KB	Share
BIT	Biotron Share Purchase Plan	PRICE SENSITIVE	24/02/09	27.25KB	Share
BIT	Half Yearly Report and Accounts	PRICE SENSITIVE	12/02/09	167.15KB	Share
BIT	BIT225 HIV Data Presented at International Meeting		12/02/09	34.82KB	Share
BIT	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/09	56.04KB	Share

BITNew Issue - Appendix 3B
04/04/11	PRICE SENSITIVE	116.25KB	Share
BITPresentation to Investors
31/03/11		1.42MB	Share
BITTrading Halt
31/03/11	PRICE SENSITIVE	52.38KB	Share
BITBiotron Share Purchase Plan
28/03/11		148.45KB	Share
BITLetter to Shareholders
16/03/11		309.15KB	Share
BITStage 1 of Landmark HCV Drug Trial Completed
10/03/11	PRICE SENSITIVE	52.67KB	Share
AAX +ABQ ADY CT1 AIV AKF APE DXC ARA AUK AZT AZX BBG BBL BIT BPO HPP BUL CCD CDD CLH CNH COI COK CPB CTO AQX DML DON DTG DVN EBG EMM ERA EXE FKP FLT GBP JNS GLL GPM AMN GWA HBS HIG QXR ICN IDL JIN KME LAU LDW MCC MNZ MST NHC OAK OCE OVT PAX PGL SKY PNA PNN PNR QRN RCT RFG RFX RPF RPX RUL SAP SDM SMR SUM SWL SXR TPA TPI TXN CR3 VBA VTG WBB WEC WHC WIG WTF WTPChange of Share Registry Address
07/03/11		65.93KB	Share
BITAppendix 3B
02/03/11		72.08KB	Share
BITHalf Yearly Report and Accounts
28/02/11	PRICE SENSITIVE	185.6KB	Share
BITBiotron Share Purchase Plan
24/02/11	PRICE SENSITIVE	105.07KB	Share
BITResponse to ASX Query re Appendix 4C
07/02/11	PRICE SENSITIVE	43.53KB	Share
BITAppendix 4C - quarterly
27/01/11	PRICE SENSITIVE	49.08KB	Share
BITUS BIOTECH SHOWCASE PRESENTATION
12/01/11		1.82MB	Share
BITGrant of Options and Appendices 3B and 3Y
24/12/10		67.65KB	Share
BITSecurity Trading Policy
23/12/10		65.06KB	Share
BITAppendix 3B
02/12/10		68.17KB	Share
BITResults of Meeting
26/11/10		23.3KB	Share
BITPresentation to Annual General Meeting
26/11/10		769.01KB	Share
BITInternational Study Supports Biotron's HIV Drug Approach
25/11/10	PRICE SENSITIVE	50.56KB	Share
BITAppendix 4C - quarterly
27/10/10	PRICE SENSITIVE	49.21KB	Share
BITAnnual Report and Notice of Annual General Meeting
27/10/10		4.44MB	Share
BITPresentation to Investors
20/10/10		178.38KB	Share
BITLetter to Shareholders
14/10/10		221.89KB	Share
BITPhase II HCV Trial Commenced
01/10/10	PRICE SENSITIVE	67.7KB	Share
BITPreliminary Final Report
31/08/10	PRICE SENSITIVE	966.84KB	Share
BITAppendix 4C - quarterly
30/07/10	PRICE SENSITIVE	49.29KB	Share
BITPresentation at International AIDS Conference
23/07/10	PRICE SENSITIVE	35.02KB	Share
BITLetter to Shareholders
30/06/10		269.58KB	Share
BITAppendix 3B
28/05/10		68.27KB	Share
BITChange of Director's Interest Notice
19/05/10		28.09KB	Share
BITAppointment of a Director
30/04/10		26.41KB	Share
BITAppendix 4C - quarterly
22/04/10	PRICE SENSITIVE	49.25KB	Share
BITExercise of Options and Appendix 3B
08/04/10		62.11KB	Share
BITDirector Resignation
01/04/10		27.16KB	Share
BITShareholder Update and 'Piggy Back' Options Opportunity
19/03/10		359.73KB	Share
BITBiotron HCV Drug - International Partner to Progress Trial
18/03/10	PRICE SENSITIVE	68.17KB	Share
BITHalf Yearly Report and Accounts
26/02/10	PRICE SENSITIVE	95.53KB	Share
BITAllotment and Top 20 securityholders - Options
05/02/10		38.09KB	Share
BITAppendix 4C - quarterly
27/01/10	PRICE SENSITIVE	49.19KB	Share
BITChange of Director's Interest Notices
22/01/10		34.56KB	Share
BITEntitlement Issue 23% Oversubscribed
15/01/10		21.07KB	Share
BITBreakthrough HIV Treatment Progresses
17/12/09	PRICE SENSITIVE	24.82KB	Share
BITHCV Drug Success Presented to International Conference
14/12/09	PRICE SENSITIVE	70.8KB	Share
BITOption Entitlement Issue and Appendix 3B
10/12/09	PRICE SENSITIVE	473.84KB	Share
BITTrading Halt
09/12/09	PRICE SENSITIVE	59.44KB	Share
BITResponse to ASX Query re Appendix 4C
17/11/09	PRICE SENSITIVE	67.24KB	Share
BITBIOTRON'S ANTI-HCV DRUG RECOGNISED INTERNATIONALLY
10/11/09		579.96KB	Share
BITAppendix 4C - quarterly
27/10/09	PRICE SENSITIVE	49.01KB	Share
BITResults of Meeting
16/10/09		23.16KB	Share
BITPresentation to Annual General Meeting
16/10/09		167.3KB	Share
BITShareholder Update on the Successful Hepatitis C Human Trial
14/10/09		249.63KB	Share
BITSuccessful HCV Trial Results
06/10/09	PRICE SENSITIVE	34.43KB	Share
BITAnnual Report and Notice of AGM
29/09/09		1.14MB	Share
BITPreliminary Final Report
28/08/09	PRICE SENSITIVE	305.11KB	Share
BITCompletion of Clinical Stage of HCV Trial
04/08/09	PRICE SENSITIVE	79.29KB	Share
BITAppendix 4C - quarterly
24/07/09	PRICE SENSITIVE	49.11KB	Share
BITResponse to ASX Query - Director's Interest Notice
04/05/09		67.17KB	Share
BITAppendix 4C - quarterly
29/04/09	PRICE SENSITIVE	56.03KB	Share
BITNew Issue Annoucement and HCV Trial Update
14/04/09	PRICE SENSITIVE	75.24KB	Share
BITTrading Halt
09/04/09	PRICE SENSITIVE	57.35KB	Share
BITChange of Director's Interest Notice
06/04/09		34.58KB	Share
BITLetter to Shareholders
05/03/09		126.56KB	Share
BITBiotron Share Purchase Plan
24/02/09	PRICE SENSITIVE	27.25KB	Share
BITHalf Yearly Report and Accounts
12/02/09	PRICE SENSITIVE	167.15KB	Share
BITBIT225 HIV Data Presented at International Meeting
12/02/09		34.82KB	Share
BITAppendix 4C - quarterly
30/01/09	PRICE SENSITIVE	56.04KB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.3¢		Change 0.001(25.0%)		Mkt cap ! $3.318M

Open	High	Low	Value	Volume
0.3¢	0.3¢	0.3¢	$500	200K

Buyers (Bids)

No.	Vol.	Price($)
47	36018629	0.2¢

Sellers (Offers)

Price($)	Vol.	No.
0.3¢	15608555	20

View Market Depth

No.	Vol.	Price($)
47	36018629	0.002
32	93302000	0.001
0	0	0.000
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
0.003	15608555	20
0.004	16987080	16
0.005	6690600	5
0.006	1200000	2
0.007	572733	2

Last trade - 15.15pm 31/07/2025 (20 minute delay)

BIT (ASX) Chart

BIOTRON LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available